Annual long term liabilities:
$68.41M+$4.64M(+7.28%)Summary
- As of today (September 14, 2025), LGND annual total long term liabilities is $68.41 million, with the most recent change of +$4.64 million (+7.28%) on December 31, 2024.
- During the last 3 years, LGND annual long term liabilities has fallen by -$43.38 million (-38.81%).
- LGND annual long term liabilities is now -64.35% below its all-time high of $191.89 million, reached on December 31, 2003.
Performance
LGND Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$50.71M+$3.06M(+6.42%)Summary
- As of today (September 14, 2025), LGND quarterly total long term liabilities is $50.71 million, with the most recent change of +$3.06 million (+6.42%) on June 30, 2025.
- Over the past year, LGND quarterly long term liabilities has dropped by -$15.52 million (-23.43%).
- LGND quarterly long term liabilities is now -91.73% below its all-time high of $612.88 million, reached on September 30, 2018.
Performance
LGND quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LGND Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | -23.4% |
| 3 y3 years | -38.8% | -35.8% |
| 5 y5 years | +10.8% | -15.2% |
LGND Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.8% | +22.1% | -39.9% | +6.4% |
| 5 y | 5-year | -38.8% | +22.1% | -54.6% | +6.4% |
| alltime | all time | -64.3% | +3809.7% | -91.7% | +2205.1% |
LGND Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $50.71M(+6.4%) |
| Mar 2025 | - | $47.65M(-30.3%) |
| Dec 2024 | $68.41M(+7.3%) | $68.41M(-17.2%) |
| Sep 2024 | - | $82.65M(+24.8%) |
| Jun 2024 | - | $66.23M(-21.5%) |
| Mar 2024 | - | $84.34M(+32.3%) |
| Dec 2023 | $63.77M(+13.8%) | $63.77M(-20.1%) |
| Sep 2023 | - | $79.77M(+51.0%) |
| Jun 2023 | - | $52.83M(-3.3%) |
| Mar 2023 | - | $54.65M(-2.5%) |
| Dec 2022 | $56.04M(-49.9%) | $56.04M(-12.7%) |
| Sep 2022 | - | $64.17M(-18.7%) |
| Jun 2022 | - | $78.98M(+3.8%) |
| Mar 2022 | - | $76.12M(-31.9%) |
| Dec 2021 | $111.79M(+6.8%) | $111.79M(+15.3%) |
| Sep 2021 | - | $96.94M(-0.3%) |
| Jun 2021 | - | $97.18M(+2.2%) |
| Mar 2021 | - | $95.08M(-9.2%) |
| Dec 2020 | $104.71M(+69.6%) | $104.71M(+116.2%) |
| Sep 2020 | - | $48.43M(-19.0%) |
| Jun 2020 | - | $59.82M(+19.8%) |
| Mar 2020 | - | $49.92M(-19.2%) |
| Dec 2019 | $61.75M(+3.4%) | $61.75M(+212.9%) |
| Sep 2019 | - | $19.73M(+18.2%) |
| Jun 2019 | - | $16.70M(-35.6%) |
| Mar 2019 | - | $25.93M(-56.6%) |
| Dec 2018 | $59.74M(-8.3%) | $59.74M(-90.3%) |
| Sep 2018 | - | $612.88M(+1.2%) |
| Jun 2018 | - | $605.62M(+2177.7%) |
| Mar 2018 | - | $26.59M(-59.2%) |
| Dec 2017 | $65.14M(+96.4%) | $65.14M(+137.0%) |
| Sep 2017 | - | $27.49M(-5.4%) |
| Jun 2017 | - | $29.07M(-5.9%) |
| Mar 2017 | - | $30.90M(-6.8%) |
| Dec 2016 | $33.17M(-22.8%) | $33.17M(-9.1%) |
| Sep 2016 | - | $36.48M(-7.0%) |
| Jun 2016 | - | $39.21M(-81.3%) |
| Mar 2016 | - | $209.12M(+386.8%) |
| Dec 2015 | $42.96M(+187.7%) | $42.96M(-79.9%) |
| Sep 2015 | - | $213.27M(+1140.4%) |
| Jun 2015 | - | $17.19M(+19.0%) |
| Mar 2015 | - | $14.45M(-3.2%) |
| Dec 2014 | $14.93M(-42.9%) | $14.93M(-14.3%) |
| Sep 2014 | - | $17.44M(-3.9%) |
| Jun 2014 | - | $18.14M(-6.8%) |
| Mar 2014 | - | $19.46M(-25.6%) |
| Dec 2013 | $26.16M(-9.5%) | $26.16M(+7.2%) |
| Sep 2013 | - | $24.40M(-5.3%) |
| Jun 2013 | - | $25.76M(-11.9%) |
| Mar 2013 | - | $29.26M(+1.3%) |
| Dec 2012 | $28.89M(-28.0%) | $28.89M(+116.6%) |
| Sep 2012 | - | $13.34M(-18.3%) |
| Jun 2012 | - | $16.34M(-3.8%) |
| Mar 2012 | - | $16.97M(-57.7%) |
| Dec 2011 | $40.13M(+4.0%) | $40.13M(+180.7%) |
| Sep 2011 | - | $14.29M(-65.5%) |
| Jun 2011 | - | $41.47M(-9.2%) |
| Mar 2011 | - | $45.65M(+18.3%) |
| Dec 2010 | $38.58M(-55.1%) | $38.58M(-54.8%) |
| Sep 2010 | - | $85.33M(+4.9%) |
| Jun 2010 | - | $81.34M(-9.7%) |
| Mar 2010 | - | $90.04M(+4.8%) |
| Dec 2009 | $85.89M | $85.89M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $73.54M(-21.1%) |
| Jun 2009 | - | $93.23M(-8.1%) |
| Mar 2009 | - | $101.40M(-8.8%) |
| Dec 2008 | $111.20M(+19.3%) | $111.20M(+18.9%) |
| Sep 2008 | - | $93.54M(-3.0%) |
| Jun 2008 | - | $96.39M(-1.1%) |
| Mar 2008 | - | $97.42M(+4.5%) |
| Dec 2007 | $93.19M(-27.1%) | $93.19M(-25.7%) |
| Sep 2007 | - | $125.40M(-0.6%) |
| Jun 2007 | - | $126.19M(+10.1%) |
| Mar 2007 | - | $114.56M(-10.4%) |
| Dec 2006 | $127.89M(-32.6%) | $127.89M(-50.2%) |
| Sep 2006 | - | $256.64M(+0.2%) |
| Jun 2006 | - | $256.02M(-0.4%) |
| Mar 2006 | - | $257.02M(+35.4%) |
| Dec 2005 | $189.83M(-0.7%) | $189.83M(-0.0%) |
| Sep 2005 | - | $189.87M(-0.4%) |
| Jun 2005 | - | $190.63M(-0.2%) |
| Mar 2005 | - | $190.99M(-0.0%) |
| Dec 2004 | $191.07M(-0.4%) | $191.07M(+8.5%) |
| Sep 2004 | - | $176.17M(+0.2%) |
| Jun 2004 | - | $175.85M(-0.4%) |
| Mar 2004 | - | $176.56M(-8.0%) |
| Dec 2003 | $191.89M(+15.6%) | $191.89M(+17.1%) |
| Sep 2003 | - | $163.91M(-0.5%) |
| Jun 2003 | - | $164.72M(-0.4%) |
| Mar 2003 | - | $165.33M(-0.4%) |
| Dec 2002 | $166.06M(+15.6%) | $166.06M(+1603.0%) |
| Sep 2002 | - | $9.75M(+8.8%) |
| Jun 2002 | - | $8.96M(-6.3%) |
| Mar 2002 | - | $9.57M(-93.3%) |
| Dec 2001 | $143.62M(+2.5%) | $143.62M(-0.3%) |
| Sep 2001 | - | $144.10M(-0.5%) |
| Jun 2001 | - | $144.87M(+2.3%) |
| Mar 2001 | - | $141.60M(+1.0%) |
| Dec 2000 | $140.13M(+0.5%) | $140.13M(+14.0%) |
| Sep 2000 | - | $122.90M(+1.2%) |
| Jun 2000 | - | $121.42M(+1.3%) |
| Mar 2000 | - | $119.81M(-14.1%) |
| Dec 1999 | $139.50M(-0.7%) | $139.50M(-11.4%) |
| Sep 1999 | - | $157.50M(+18.6%) |
| Jun 1999 | - | $132.80M(+1.3%) |
| Mar 1999 | - | $131.10M(-6.7%) |
| Dec 1998 | $140.50M(+173.3%) | $140.50M(+40.9%) |
| Sep 1998 | - | $99.70M(+103.9%) |
| Jun 1998 | - | $48.90M(-6.3%) |
| Mar 1998 | - | $52.20M(+1.6%) |
| Dec 1997 | $51.40M(-4.5%) | $51.40M(+3.6%) |
| Sep 1997 | - | $49.60M(-3.9%) |
| Jun 1997 | - | $51.60M(+1.6%) |
| Mar 1997 | - | $50.80M(-5.6%) |
| Dec 1996 | $53.80M(+8.0%) | $53.80M(+12.1%) |
| Sep 1996 | - | $48.00M(-6.6%) |
| Jun 1996 | - | $51.40M(+1.6%) |
| Mar 1996 | - | $50.60M(+1.6%) |
| Dec 1995 | $49.80M(+304.9%) | $49.80M(+0.4%) |
| Sep 1995 | - | $49.60M(+313.3%) |
| Mar 1995 | - | $12.00M(-2.4%) |
| Dec 1994 | $12.30M(+429.2%) | $12.30M(0.0%) |
| Sep 1994 | - | $12.30M(+412.5%) |
| Jun 1994 | - | $2.40M(+9.1%) |
| Mar 1994 | - | $2.20M |
| Dec 1993 | $2.32M(+32.8%) | - |
| Dec 1992 | $1.75M | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total long term liabilities?
- What is the all time high annual long term liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total long term liabilities?
The current annual long term liabilities of LGND is $68.41M
What is the all time high annual long term liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total long term liabilities is $191.89M
What is Ligand Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
Over the past year, LGND annual total long term liabilities has changed by +$4.64M (+7.28%)
What is Ligand Pharmaceuticals Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of LGND is $50.71M
What is the all time high quarterly long term liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total long term liabilities is $612.88M
What is Ligand Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
Over the past year, LGND quarterly total long term liabilities has changed by -$15.52M (-23.43%)